A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a ...

BioReference Health LLC, formerly known as BioReference Laboratories Inc., and OPKO Health (OPK) Inc. have agreed to pay $704,349 to resolve ...

A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous ...

The test uses a combination of antibodies and enzymes to identify the target molecule, producing a measurable colour change if the target is present. The sample, such as blood, saliva, or another ...

That can take several days or weeks. They can also be messy if they’re urine-based or invasive if blood-based. The advantage of this type of test is it doesn’t require another party and can ...